In 2021, doctors were informed by Regional Health Agencies that these injections were likely to cause pericarditis and myocarditis.

An analysis of clinical trial data from Pfizer-BioNTech's COVID-19 vaccine, published this month in the International Journal of Vaccine Theory, Practice, and Research, shows that vaccine makers hid data from regulators on deaths in order to qualify for emergency use authorization.

Pfizer-BioNTech has delayed the release of vaccine-associated deaths among participants in the BNT162b2 clinical trial until the Food and Drug Administration (FDA) issues an Emergency Use Authorization (EUA) for this vaccine .

With COVID 19 deemed a national health emergency, regulators have abandoned the established, patient-centered, safety-based approval process that requires years of preclinical animal testing that is otherwise almost all died during the tests.

Doctors knew the risks.

As for compulsory covid vaccination for the medical profession, some doctors preferred to receive the injection in the thighs rather than in the arm. The shoulder is a body area closer to the heart and the migration of the injected product can potentially affect the heart area and cause pericarditis and myocarditis.

The disadvantages of injections into the thighs have been found to be different in terms of side effects.
A general practitioner whose name cannot be revealed due to his possible suspension by the medical order noticed disseminated intravascular coagulation on his thighs after receiving his third injection.
The clinical signs were varicosities on the legs as well as difficulty walking with a feeling of heaviness and difficulty during exercise.

Disseminated intravascular coagulation (DIC) results in excess generation of thrombin and fibrin in the circulation. The manifestations of DIC are venous thromboembolic phenomena which lead to heart failure.

Many vaccine recipients saw their D-dimer levels increase after the injection. (D-dimer comes from the breakdown of fibrin, a protein involved in blood clotting). Their blood tests showed that if their D-dimer level was very high, there was a risk of developing a thrombosis. Other cases of DIC have produced bleeding in the nose, ears and intimate passages.

Thrombosis and cancer

Disseminated intravascular coagulation is a complex hemostasis anomaly with dramatic consequences and has long been described as associated with tumor pathologies. The cancer screening assessment following venous thromboembolism (VTE) currently remains controversial. The serological finding of thrombosis and D-dimer greater than 3,8 μg/mL are highly associated with oncological pathology.

The tumor stroma is a fertile breeding ground for cancer cells; it is made up of connective tissue serving as support or nourishing tissue for tumor proliferation in which it develops.

In 2017, INSERM noted that fibronectin (fibrin) is necessary and essential for tumor progression. Fibronectin is a glycoprotein present in soluble form in physiological fluids such as blood plasma. It is involved in the process of thrombosis and healing. Fibronectin is used as a cell attachment factor when used in cell culture.

To summarize, if after a covid injection your D Dimer level increases, it is because you are activating the production of fibrin with a potential risk of tumor stroma.
In the formation of a cancer cell; we see that the vascular network is anarchic and has high permeability.

Vascular problems are therefore a major risk factor for cancer, if a vaccine injection leads to either thrombosis, DIC or tumor stroma.

read the article